Background and activities
Scientific, academic and artistic work
A selection of recent journal publications, artistic productions, books, including book and report excerpts. See all publications in the database
- (2022) Phosphatases of regenerating liver are key regulators of metabolism in cancer cells - role of Serine/Glycine metabolism. Current opinion in clinical nutrition and metabolic care. vol. 25 (1).
- (2022) Highly expressed genes in multiple myeloma cells – what can they tell us about the disease?. European Journal of Haematology.
- (2021) Phosphatase of Regenerating Liver-3 Regulates Cancer Cell Metabolism in Multiple Myeloma. The FASEB Journal.
- (2021) Targeting phosphoglycerate dehydrogenase in multiple myeloma. Experimental hematology and oncology.
- (2021) PRL-3 induces a positive signaling circuit between glycolysis and activation of STAT1/2. The FEBS Journal. vol. 288 (23).
- (2020) Protein tyrosine phosphatases in multiple myeloma. Cancer Letters.
- (2020) Conversion of ATP to adenosine by CD39 and CD73 in multiple myeloma can be successfully targeted together with adenosine receptor A2A blockade. Journal for ImmunoTherapy of Cancer (JITC).
- (2018) Phosphatase of regenerating liver-3 (PRL-3) is overexpressed in classical Hodgkin lymphoma and promotes survival and migration. Experimental hematology and oncology. vol. 7:8.
- (2017) Phosphatase of regenerating liver-3 is expressed in acute lymphoblastic leukemia and mediates leukemic cell adhesion, migration and drug resistance. OncoTarget. vol. 9 (3).
- (2016) Src family kinases are regulated in multiple myeloma cells by phosphatase of regenerating liver-3. Molecular Cancer Research. vol. 15 (1).
- (2016) The phosphatase of regenerating liver-3 (PRL-3) is importantfor IL-6-mediated survival of myeloma cells. OncoTarget. vol. 7 (19).
- (2016) Phosphatase of regenerating liver 3 (PRL-3) is overexpressed in human prostate cancer tissue and promotes growth and migration. Journal of Translational Medicine. vol. 14 (71).
- (2014) PRL-3 Mediates Survival of Primary Myeloma Cells. Blood. vol. 124.